Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic Patients

Roman G. Judzewitsch, Jonathan B. Jaspan, Kenneth S. Polonsky, Clarice R. Weinberg, Jeffrey B. Halter, Eugen Halar, Michael A. Pfeifer, Cynthia Vukadinovic, Lawrence Bernstein, Michael Schneider, Kung Yee Liang, Kenneth H. Gabbay, Arthur H. Rubenstein, Daniel Porte

Research output: Contribution to journalArticlepeer-review

Abstract

To assess the potential role of polyol-pathway activity in diabetic neuropathy, we measured the effects of sorbinil — a potent inhibitor of the key polyol-pathway enzyme aldose reductase — on nerve conduction velocity in 39 stable diabetics in a randomized, double-blind, cross-over trial. During nine weeks of treatment with sorbinil (250 mg per day), nerve conduction velocity was greater than during a nine-week placebo period for all three nerves tested: the peroneal motor nerve (mean increase [±S.E.M.], 0.70±0.24 m per second, P<0.008), the median motor nerve (mean increase, 0.66±0.27, P<0.005), and the median sensory nerve (mean increase, 1.16±0.50, P<0.035). Conduction velocity for all three nerves declined significantly within three weeks after cessation of the drug. These effects of sorbinil were not related to glycemic control, which was constant during the study. Although the effect of sorbinil in improving nerve conduction velocity in diabetics was small, the findings suggest that polyol-pathway activity contributes to slowed nerve conduction in diabetics. The clinical applicability of these observations remains to be determined, but they encourage further exploration of this approach to the treatment or prevention of diabetic neuropathy. (N Engl J Med. 1983; 308:119–25.).

Original languageEnglish (US)
Pages (from-to)119-125
Number of pages7
JournalNew England Journal of Medicine
Volume308
Issue number3
DOIs
StatePublished - Jan 20 1983

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic Patients'. Together they form a unique fingerprint.

Cite this